AU Patent

AU2022246286A1 — A process for the preparation of mixed oxybate salts and polymorphs thereof

Assigned to Alkem Laboratories Ltd · Expires 2023-09-07 · 3y expired

What this patent protects

The present invention provides an improved scalable process for preparation of mixed oxybate salts. More particularly, the present invention provides a process of preparation of a mixture of sodium, potassium, magnesium and calcium oxybate salts. Further, the present invention pr…

USPTO Abstract

The present invention provides an improved scalable process for preparation of mixed oxybate salts. More particularly, the present invention provides a process of preparation of a mixture of sodium, potassium, magnesium and calcium oxybate salts. Further, the present invention provides polymorphs of each of the individual salts and the mixed salt along with the methods of preparation of each.

Drugs covered by this patent

Patent Metadata

Patent number
AU2022246286A1
Jurisdiction
AU
Classification
Expires
2023-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Alkem Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.